Glenn Sblendorio Amicus Therapeutics, Inc. (FOLD) insider trading activity

Glenn Sblendorio is of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 115,857 shares of FOLD, which is worth approximately $1.05 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 20,414 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K

0% 3M change

21.39% 12M change

Total Value Held $1.05 Million

GLENN SBLENDORIO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	20,414 Added 14.98%	115,857 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	11,847 Added 11.04%	95,443 Common Stock
Mar 07 2024	BUY Exercise of conversion of derivative security	$42,000 $2.8 p/Share	15,000 Added 15.21%	83,596 Common Stock
Jun 08 2023	BUY Grant, award, or other acquisition	-	8,584 Added 8.26%	95,303 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	$49,800 $3.32 p/Share	15,000 Added 14.75%	86,719 Common Stock
Jun 09 2022	BUY Grant, award, or other acquisition	-	12,671 Added 15.01%	71,719 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	$71,850 $4.79 p/Share	15,000 Added 20.26%	59,048 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	-	10,115 Added 18.68%	44,048 Common Stock

Also insider at

ISEE

IVERIC bio, Inc. Healthcare

Chief Executive Officer

ICPT

INTERCEPT PHARMACEUTICALS, INC. Healthcare

Director

MLYS

Mineralys Therapeutics, Inc.

Director